La Rosée, the French dermocosmetics brand founded by pharmacists Coline Bertrand and Manhault de Guilbert in 2015, may be sold before year-end, according to industry sources. Both strategic buyers and investment funds have expressed interest in acquiring the brand.

The company has grown rapidly since its launch. It started in 300 French pharmacies and now operates in upward of 9,500 locations across 13 countries. La Rosée is the fourth bestselling dermocosmetics brand in French pharmacies. Yearly sales exceed 100 million euros.

The brand's product range expanded from five initial offerings to more than 40 items, spanning baby care and hair care. Its refillable deodorant and sun care stick are top sellers. Products average 14 euros and contain up to 100 percent natural origin ingredients. Most packaging uses plant-based materials like sugarcane.

International expansion has accelerated. La Rosée entered Canada this year and operates in more than 540 Shopper Drug Mart stores there. In South Korea, where the brand launched in 2022, sales top 10 million euros.

In August 2023, FG Bros, the Belgian family office of Ségolène Frère and Ian Gallienne, acquired 20 percent of La Rosée.

The dermocosmetics category is the fastest-growing segment within skin care. The market currently values 54.41 billion dollars and is estimated to reach 80.29 billion dollars by 2031, representing an 8.1 percent annual growth rate, according to Mordor Intelligence. Other players like Puig, L'Oréal, and Beiersdorf are expanding their dermocosmetics portfolios.